|
Autologous CAR-T cell therapy expressing the BAFF-ligand. Clinical Trials
1 actively recruiting trial across 1 location
Cleveland, Ohio1 trial
LMY-920 for Treatment of Relapsed or Refractory Myeloma
University Hospitals Seidman Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.